25,618
Views
9
CrossRef citations to date
0
Altmetric
Review

Impact of intermittent fasting on human health: an extended review of metabolic cascades

, , , , , , , & show all
Pages 2700-2713 | Received 11 Aug 2018, Accepted 08 Dec 2018, Published online: 06 Jan 2019

References

  • Fontana, L.; Partridge, L. Promoting Health and Longevity through Diet: From Model Organisms to Humans. Cell. 2015, 161, 106e118. DOI: 10.1016/j.cell.2015.02.020.
  • Johnstone, A. Fasting for Weight Loss: An Effective Strategy or Latest Dieting Trend? Int. J. Obes. 2015, 39, 727–733. DOI: 10.1038/ijo.2014.214.
  • Abreu-Vieira, G.; Xiao, C.; Gavrilova, O.; Reitman, M.-L. Integration of Body Temperature into the Analysis of Energy Expenditure in the Mouse. Mol. Metab. 2015, 4, 461e470. DOI: 10.1016/j.molmet.2015.03.001.
  • Patterson, R.-E.; Laughlin, G.-A.; LaCroix, A.-Z.; Hartman, S.-J.; Natarajan, L.; Senger, C.-M.; Martínez, M. E.; Villaseñor, A.; Sears, D. D.; Marinac, C. R.; et al. Intermittent Fasting and Human Metabolic Health. J. Acad. Nutr. Diet. 2015, 115, 1203e1212. DOI: 10.1016/j.jand.2015.02.018.
  • Most, J.; Tosti, V.; Redman, L.-M.; Fontana, L. Calorie Restriction in Humans: An Update. Ageing Res. Rev. 2016. DOI: 10.1016/j.arr2016.08.005.
  • Anastasiou, C.-A.; Karfopoulou, E.; Yannakoulia, M. Weight Regaining: From Statistics and Behaviors to Physiology and Metabolism. Metabolism. 2015, 64, 1395–1407. DOI: 10.1016/j.metabol.2015.08.006.
  • Brandhorst, S.; Choi, I.-Y.; Wei, M.; Cheng, C.; Sedrakyan, S.; Navarrete, G.; Dubeau, L.; Yap, L.; Park, R.; Vinciguerra, M.; et al. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. Cell Metab. 2015, 22(1), 86–99. DOI: 10.1016/j.cmet.2015.05.012.
  • Mundstock, E.; Sarria, -E.-E.; Zatti, H.; Mattos Louzada, F.; Kich Grun, L.; Herbert Jones, M.; Guma, F. T.; Mazzola In Memoriam, J.; Epifanio, M.; Stein, R.-T.; et al. Effect of Obesity on Telomere Length: Systematic Review and Meta-Analysis. Obesity (Silver Spring). 2015, 23, 2165–2174. DOI: 10.1002/oby.21183.
  • Gotthardt, J.-D.; Verpeut, J.-L.; Yeomans, B.-L.; Yang, J.-A.; Yasrebi, A.; Roepke, T.-A.; Bello, N.-T. Intermittent Fasting Promotes Fat Loss with Lean Mass Retention, Increased Hypothalamic Norepinephrine Content, and Increased Neuropeptide Y Gene Expression in Diet-Induced Obese Male Mice. Endocrinology. 2016, 157, 679–691. DOI: 10.1210/en.2015-1622.
  • Gao, Q.; Jia, Y.; Yang, G.; Zhang, X.; Boddu, P.-C.; Petersen, B.; Narsingam, S.; Zhu, Y.-J.; Thimmapaya, B.; Kanwar, Y. S.; et al. PPARalpha-deficient Ob/Ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation. Am. J. Pathol. 2015, 185, 1396e1408. DOI: 10.1016/j.ajpath.2015.01.018.
  • Kim, S.-H.; Chun, H.-J.; Choi, H.-S.; Kim, E.-S.; Keum, B.; Jeen, Y.-T. Current Status of Intragastric Balloon for Obesity Treatment. World J. Gastroenterol. 2016, 22, 5495–5504. DOI: 10.3748/wjg.v22.i37.8314.
  • Horne, B.-D.; Muhlestein, J.-B.; Anderson, J.-L. Health Effects of Intermittent Fasting: Hormesis or Harm? A Systematic Review. Am. J. Clin. Nutr. 2015, 102(2), 464–470. DOI: 10.3945/ajcn.115.109553.
  • Habermann, N.; Makar, K.-W.; Abbenhardt, C.; Xiao, L.; Wang, C.-Y.; Utsugi, H.-K.; Alfano, C.-M.; Campbell, K.-L.; Duggan, C.; Foster-Schubert, K.-E.; et al. No Effect of Caloric Restriction or Exercise on Radiation Repair Capacity. Med. Sci. Sports Exercise. 2015, 47, 896–904. DOI: 10.1249/MSS.0000000000000651.
  • Martin, K.; Jackson, C.-F.; Levy, R.-G.; Cooper, P.-N. Ketogenic Diet and Other Dietary Treatments for Epilepsy. Cochrane Database Syst. Rev. 2016, 2, CD001903. DOI: 10.1002/14651858.CD004158.pub3.
  • Das, J. K.; Lassi, Z. S.; Hoodbhoy, Z.; Salam, R. A. Nutrition for the Next Generation: Older Children and Adolescents. Ann. Nutr. Metab. 2018, 72(3), 56–64. DOI: 10.1159/000487385.
  • Adrienne, R.; Kristin, K.; Terry, G.; Krista, A. Intermittent Fasting Vs Daily Calorie Restriction for Type 2 Diabetes Prevention: A Review of Human Findings. Transl. Res. 2014, 164(4), 302–311. DOI: 10.1016/j.trsl.2014.05.013.
  • Tatulli, G.; Mitro, N.; Cannata, M.; Audano, M.; Caruso, D.; D’Arcangelo, G.; Lettieri-Barbato, D.; Aquilano, K. Intermittent Fasting Applied in Combination with Rotenone Treatment Exacerbates Dopamine Neurons Degeneration in Mice. Front. Cell. Neurosci. 2018, 12, 4. DOI: 10.3389/fncel.2018.00191.
  • Renehan, A.-G.; Tyson, M.; Egger, M.; Heller, R. F.; Zwahlen, M. Body-Mass Index and Incidence of Cancer: A Systematic Review and Meta-Analysis of Prospective Observational Studies. Lancet. 2008, 371, 569–578. DOI: 10.1016/S0140-6736(08)60269-X.
  • Lv, M.; Zhu, X.; Wang, H.; Wang, F.; Guan, W. Roles of Caloric Restriction, Ketogenic Diet and Intermittent Fasting during Initiation, Progression and Metastasis of Cancer in Animal Models: A Systematic Review and Meta-Analysis. PLoS One. 2014, 9(12), e115147. DOI: 10.1371/journal.pone.0115147.
  • Lashinger, L.-M.; O’Flanagan, C.-H.; Dunlap, S.-M.; Rasmussen, A.-J.; Sweeney, S.; Guo, J.-Y.; Lodi, A.; Tiziani, S.; White, E.; Hursting, S.-D. Starving Cancer from the outside and Inside: Separate and Combined Effects of Calorie Restriction and Autophagy Inhibition on Ras-Driven Tumors. Cancer Metab. 2016, 4, 18. DOI: 10.1186/s40170-016-0158-4.
  • Armitage, C.-J.; Wright, C.-L.; Pegington, M.; McKee, M.; Knai, C. Self- Efficacy for Temptations Is a Better Predictor of Weight Loss than Motivation and Global Self-Efficacy: Evidence from Two Prospective Studies among Overweight/Obese Women at High Risk of Breast Cancer. Patient Educ. Couns. 2014, 95, 254–258. DOI: 10.1016/j.pec.2013.12.013.
  • Galluzzi, L.; Pietrocola, F.; Bravo-San Pedro, J.-M.; Amaravadi, R.-K.; Baehrecke, E.-H.; Cecconi, F.; Codogno, P.; Debnath, J.; Gewirtz, D.-A.; Karantza, V.; et al. Autophagy in Malignant Transformation and Cancer Progression. Embo J. 2015, 34(7), 856–880. DOI: 10.15252/embj.201490784.
  • Bowers, L.-W.; Rossi, E.-L.; O’Flanagan, C.-H.; de Graffenried, L.-A.; Hursting, S.-D. The Role of the insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link. Front. Endocrinol. 2015, 6, 77. DOI: 10.3389/fendo.2015.00077.
  • Lauby-Secretan, B.; Scoccianti, C.; Loomis, D.; Grosse, Y.; Bianchini, F.; Straif, K. International Agency for Research on Cancer Handbook Working G: Body Fatness and Cancer – Viewpoint of the IARC Working Group. New Engl. J. Med. 2016, 375, 794–798. DOI: 10.1056/NEJMsr1606602.
  • De Groot, S.; Vreeswijk, M.-P.; Welters, M.-J.; Gravesteijn, G.; Boei, -J.-J.; Jochems, A.; Houtsma, D.; Putter, H.; van der Hoeven, -J.-J.; Nortier, J.-W.;; et al. The Effects of Short-Term Fasting on Tolerance to (Neo) Adjuvant Chemotherapy in HER2-negative Breast Cancer Patients: A Randomized Pilot Study. BMC Cancer. 2015, 15, 652. DOI: 10.1186/s12885-015-1584-3.
  • Altman, B.-J.; Stine, Z.-E.; Dang, C.-V. From Krebs to Clinic: Glutamine Metabolism to Cancer Therapy. Nat. Rev. Cancer. 2016, 16(10), 619–634. DOI: 10.1038/nrc.2016.71.
  • Cifarelli, V.; Lashinger, L.-M.; Devlin, K.-L.; Dunlap, S.-M.; Huang, J.; Kaaks, R.; Pollak, M.-N.; Hursting, S.-D. Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct microRNA-regulated Mechanisms. Diabetes. 2015, 64(5), 1632–1642. DOI: 10.2337/db14-1560.
  • Harvey, A.-E.; Lashinger, L.-M.; Hays, D.; Harrison, L.-M.; Lewis, K.; Fischer, S.-M.; Hursting, S.-D. Calorie Restriction Decreases Murine and Human Pancreatic Tumor Cell Growth, Nuclear factor-kappaB Activation, and Inflammation-Related Gene Expression in an Insulin-Like Growth Factor-1-Dependent Manner. PLoS One. 2014, 9(5), e94151. DOI: 10.1371/journal.pone.0094151.
  • Farazi, M.; Nguyen, J.; Goldufsky, J.; Linnane, S.; Lukaesko, L.; Weinberg, A.-D.; Ruby, C.-E. Caloric Restriction Maintains OX40 Agonist-Mediated Tumor Immunity and CD4 T Cell Priming during Aging. Cancer Immunol. Immunother. 2014, 63(6), 615–626. DOI: 10.1007/s00262-014-1542-y.
  • Marosi, K.; Kim, S.-W.; Moehl, K.; Scheibye-Knudsen, M.; Cheng, A.; Cutler, R.; Camandola, S.; Mattson, M.-P. 3-Hydroxybutyrate Regulates Energy Metabolism and Induces BDNF Expression in Cerebral Cortical Neurons. J. Neurochem. 2016, 139, 769–781. DOI: 10.1111/jnc.13868.
  • Houten, S.-M.; Violante, S.; Ventura, F.-V.; Wanders, R.-J. The Biochemistry and Physiology of Mitochondrial Fatty Acid Beta-Oxidation and Its Genetic Disorders. Annu. Rev. Physiol. 2016, 78, 23e44. DOI: 10.1146/annurev-physiol-021115-105045.
  • Sancar, A.; Lindsey-Boltz, L.-A.; Gaddameedhi, S.; Selby, C.-P.; Ye, R.; Chiou, -Y.-Y.; Kemp, M.-G.; Hu, J.; Lee, J.-H.; Ozturk, N. Circadian Clock, Cancer, and Chemotherapy. Biochemistry. 2015, 54(2), 110–123. DOI: 10.1021/bi5007354.
  • Denduluri, S.-K.; Idowu, O.; Wang, Z.; Liao, Z.; Yan, Z.; Mohammed, M.-K.; Ye, J.; Wei, Q.; Wang, J.; Zhao, L.; et al. Insulin-Like Growth Factor (IGF) Signaling in Tumorigenesis and the Development of Cancer Drug Resistance. Genes Dis. 2015, 2(1), 13–25. DOI: 10.1016/j.gendis.2014.10.004.
  • Cheng, C.-W.; Adams, G.-B.; Perin, L.; Wei, M.; Zhou, X.; Lam, B.-S.; Da Sacco, S.; Mirisola, M.; Quinn, D.-I.; Dorff, T.-B. Prolonged Fasting Reduces IGF-1/PKA to Promote Hematopoietic-Stem-Cell-Based Regeneration and Reverse Immunosuppression. Cell Stem Cell. 2014, 14(6), 810–823. DOI: 10.1016/j.stem.2014.04.014.
  • Wright, C.-E.; Harvie, M.-N.; Howell, A.; Evans, D. G.; Hulbert-Williams, N.; Donnelly, L. S. Beliefs about Weight and Breast Cancer: An Interview Study with High Risk Women following a 12 Month Weight Loss Intervention. Hered. Cancer Clin. Pract. 2015, 13, 1. DOI: 10.1186/s13053-014-0023-9.
  • Pietrocola, F.; Pol, J.; Vacchelli, E.; Rao, S.; Enot, D.-P.; Baracco, -E.-E.; Levesque, S.; Castoldi, F.; Jacquelot, N.; Yamazaki, T.; et al. Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer Cell. 2016, 30(1), 147–160. DOI: 10.1016/j.ccell.2016.05.016.
  • Schwartz, L.; Buhler, L.; Icard, P.; Lincet, H.; Steyaert, J.-M. Metabolic Treatment of Cancer: Intermediate Results of a Prospective Case Series. Anticancer Res. 2014, 34(2), 973–980.
  • Newman, J.-C.; Covarrubias, A.-J.; Zhao, M.; Yu, X.; Gut, P.; Ng, C.-P.; Huang, Y.; Haldar, S.; Verdin, E. Ketogenic Diet Reduces Midlife Mortality and Improves Memory in Aging Mice. Cell Metab. 2017, 26, 547–557. DOI: 10.1016/j.cmet.2017.08.004.
  • Klement, R.-J.; Champ, C.-E. Calories, Carbohydrates, and Cancer Therapy with Radiation: Exploiting the Five R’s through Dietary Manipulation. Cancer Metastasis Rev. 2014, 33(1), 217–229. DOI: 10.1007/s10555-014-9495-3.
  • Harvie, M.-N.; Sims, A.-H.; Pegington, M.; Spence, K.; Mitchell, A.; Vaughan, -A.-A.; Allwood, J.-W.; Xu, Y.; Rattray, N.-J.; Goodacre, R.; et al. Intermittent Energy Restriction Induces Changes in Breast Gene Expression and Systemic Metabolism. Breast Cancer Res. 2016, 18(1), 57. DOI: 10.1186/s13058-016-0714-4.
  • Kelly, A.-S.; Ryder, J.-R.; Marlatt, K.-L.; Rudser, K.-D.; Jenkins, T.; Inge, T.-H. Changes in Inflammation, Oxidative Stress and Adipokines following Bariatric Surgery among Adolescents with Severe Obesity. Int. J. Obes. 2016, 40, 275–280. DOI: 10.1038/ijo.2015.174.
  • Toth, C.; Clemens, Z. Halted Progression of Soft Palate Cancer in a Patient Treated with the Paleolithic Ketogenic Diet Alone: A 20-Months Follow-Up. Am. J. Case Rep. 2016, 4(8), 288–292.
  • Yang, W.; Cao, M.; Mao, X.; Wei, X.; Li, X.; Chen, G.; Zhang, J.; Wang, Z.; Shi, J.; Huang, H.; et al. Alternate-Day Fasting Protects the Livers of Mice against High-Fat Diet-Induced Inflammation Associated with the Suppression of Toll-Like Receptor 4/Nuclear Factor kappaB Signaling. Nutr. Res. 2016, 36, 586e593. DOI: 10.1016/j.nutres.2016.02.001.
  • OFlanagan, C.-H.; Bowers, L.-W.; Hursting, S.-D. A Weighty Problem: Metabolic Perturbations and the Obesity-Cancer Link. Horm. Mol. Biol. Clin. Invest. 2015, 23(2), 47–57.
  • Lu, Y.; Hajifathalian, K.; Ezzati, M.; Woodward, M.; Rimm, E.-B.; Danaei, G. Metabolic Mediators of the Effects of Body-Mass Index, Overweight, and Obesity on Coronary Heart Disease and Stroke: A Pooled Analysis of 97 Prospective Cohorts with 1·8 Million Participants. Lancet. 2014, 383, 970–983. DOI: 10.1016/S0140-6736(13)61612-8.
  • Schwartz, K.; Chang, H.-T.; Nikolai, M.; Pernicone, J.; Rhee, S.; Olson, K.; Kurniali, P.-C.; Hord, N.-G.; Noel, M. Treatment of Glioma Patients with Ketogenic Diets: Report of Two Cases Treated with an IRB-approved Energy-Restricted Ketogenic Diet Protocol and Review of the Literature. Cancer Metab. 2015, 3, 3. DOI: 10.1186/s40170-015-0129-1.
  • Eltzschig, H.-K.; Eckle, T. Ischemia and Reperfusion–From Mechanism to Translation. Nat. Med. 2011, 17, 1391–1401. DOI: 10.1038/nm.2507.
  • Secor, S.-M.; Carey, H.-V. Integrative Physiology of Fasting. Compr. Physiol. 2016, 6, 773e825. DOI: 10.1002/cphy.cv06i02corr.
  • Erkanli, K.; Erkanli Senturk, G.; Aydin, U.; Arbak, S.; Ercan, F.; Tuncdemir, M.; Isiksacan, N.; Bakir, I. Oxytocin Protects Rat Skeletal Muscle against Ischemia/Reperfusion Injury. Ann. Vasc. Surg. 2013, 27, 662–670. DOI: 10.1016/j.avsg.2012.10.012.
  • Trepanowski, J.-F.; Kroeger, C.-M.; Barnosky, A.; Klempel, M. C.; Bhutani, S.; Hoddy, K. K.; Gabel, K.; Freels, S.; Rigdon, J.; Rood, J.; et al. Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection among Metabolically Healthy Obese Adults: A Randomized Clinical Trial. JAMA Intern. Med. 2017, 177(7), 930–938. DOI: 10.1001/jamainternmed.2017.0936.
  • Seimon, R.-V.; Roekenes, J.-A.; Zibellini, J.; Zhu, B.; Gibson, -A.-A.; Hills, A.-P.; Wood, R.-E.; King, N.-A.; Byrne, N.-M.; Sainsbury, A. Do Intermittent Diets Provide Physiological Benefits over Continuous Diets for Weight Loss? A Systematic Review of Clinical Trials. Mol. Cell. Endocrinol. 2015, 418(2), 153–172. DOI: 10.1016/j.mce.2015.09.014.
  • Wang, S.; Zhang, H.; Xu, Y. Crosstalk between Microglia and T Cells Contributes to Brain Damage and Recovery after Ischemic Stroke. Neurol. Res. 2016, 38, 495–503. DOI: 10.1080/01616412.2016.1188473.
  • Fann, D.-Y.; Ng, G.-Y.; Poh, L.; Arumugam, T.-V. Positive Effects of Intermittent Fasting in Ischemic Stroke. Exp. Gerontology. 2017, 89, 93–102. DOI: 10.1016/j.exger.2017.01.014.
  • Newman, J.-C.; Verdin, E. beta-Hydroxybutyrate: A Signaling Metabolite. Annu. Rev. Nutr. 2017, 37, 51–76. DOI: 10.1146/annurev-nutr-071816-064916.
  • Camandola, S.; Mattson, M.-P. Brain Metabolism in Health, Aging, and Neurodegeneration. Embo J. 2017, 36, 1474–1492. DOI: 10.15252/embj.201695810.
  • Arumugam, T.-V.; Manzanero, S.; Furtado, M.; Biggins, P.-J.; Hsieh, Y.-H.; Gelderblom, M.; MacDonald, K.-P.; Salimova, E.; Li, Y.-I.; Korn, O.; et al. An Atypical Role for the Myeloid Receptor Mincle in Central Nervous System Injury. J. Cereb. Blood Flow Metab. 2017, 37, 2098–2111. DOI: 10.1177/0271678X16661201.
  • Wei, M.; Brandhorst, S.; Shelehchi, M.; Mirzaei, H.; Cheng, C.-W.; Budniak, J.; Groshen, S.; Mack, W.-J.; Guen, E.; Di Biase, S.; et al. Fasting-Mimicking Diet and Markers/Risk Factors for Aging, Diabetes, Cancer, and Cardiovascular Disease. J. Transl. Med. 2017, 9(377), eaai870. DOI: 10.1126/scitranslmed.aai8700.
  • Moro, T.; Tinsley, G.; Bianco, A. Effects of Eight Weeks of Time-Restricted Feeding (16/8) on Basal Metabolism, Maximal Strength, Body Composition, Inflammation, and Cardiovascular Risk Factors in Resistance-Trained Males. J. Transl. Med. 2016, 14(1), 290. DOI: 10.1186/s12967-016-0867-z.
  • Jankowski, M.; Broderick, T.-L.; Gutkowska, J. Oxytocin and Cardioprotection in Diabetes and Obesity. BMC Endocr. Disord. 2016, 16, 34. DOI: 10.1186/s12902-016-0110-1.
  • Kaneko, Y.; Pappas, C.; Tajiri, N.; Borlongan, C.-V. Oxytocin Modulates GABAAR Subunits to Confer Neuroprotection in Stroke in Vitro. Sci. Rep. 2016, 6, 35659. DOI: 10.1038/srep35659.
  • Longo, V.-D.; Panda, S. Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan. Cell Metab. 2016, 23(6), 1048–1059. DOI: 10.1016/j.cmet.2015.10.016.
  • Stonge, M.-P.; Ard, J.; Baskin, M.-L. Meal Timing and Frequency: Implications for Cardiovascular Disease Prevention: A Scientific Statement from the American Heart Association. Circulation. 2017, 135(9), e96–e121. DOI: 10.1161/CIRCULATIONAHA.117.027305.
  • Lok, K.-Z.; Basta, M.; Manzanero, S.; Arumugam, T.-V. Intravenous Immunoglobulin (Ivig) Dampens Neuronal Toll-Like Receptor-Mediated Responses in Ischemia. J. Neuroinflammation. 2015, 12, 73. DOI: 10.1186/s12974-015-0294-8.
  • Barnes, D.-E.; Yaffe, K. The Projected Effect of Risk Factor Reduction on Alzheimer’s Disease Prevalence. Lancet Neurol. 2011, 10, 819–828. DOI: 10.1016/S1474-4422(11)70072-2.
  • Dupuis, N.; Curatolo, N.; Benoist, J.-F.; Auvin, S. Ketogenic Diet Exhibits Anti-Inflammatory Properties. Epilepsia. 2015, 56(7), e95–8. DOI: 10.1111/epi.2015.56.issue-7.
  • Marseglia, L.; Mantim, S.; D’Angelo, G.; Nicotera, A.; Parisi, E.; Di Rosa, G.; Gitto, E.; Arrigo, T. Oxidative Stress in Obesity: A Critical Component in Human Diseases. Int. J. Mol. Sci. 2015, 16, 378–400. DOI: 10.3390/ijms16010378.
  • Duggan, C.; Tapsoba, J.-D.; Wang, C.-Y.; Campbell, K.-L.; Foster-Schubert, K.; Gross, M.-D.; McTiernan, A. Dietary Weight Loss, Exercise, and Oxidative Stress in Postmenopausal Women: A Randomized Controlled Trial. Cancer Prev. Res. (Phila). 2016, 9, 835–843. DOI: 10.1158/1940-6207.CAPR-16-0163.
  • Schmatz, R.; Bitencourt, M.-R.; Patias, L.-D.; Beck, M.; Da, C.-A.-G.; Zanini, D.; Gutierres, J.-M.; Diehl, L.-N.; Pereira, L.-B.; Leal, C.-A.; et al. Evaluation of the Biochemical, Inflammatory and Oxidative Profile of Obese Patients Given Clinical Treatment and Bariatric Surgery. Clin. Chim. Acta. 2017, 465, 72–79. DOI: 10.1016/j.cca.2016.12.012.
  • Manoogian, E.-N.; Pandam, S. Circadian Rhythms, Time-Restricted Feeding, and Healthy Aging. Ageing Res. Rev. 2017, 39, 59–67. DOI: 10.1016/j.arr.2016.12.006.
  • Wegman, M.-P.; Guo, M.-H.; Bennion, D.-M.; Shankar, M.-N.; Chrzanowski, S.-M.; Goldberg, L.-A.; Xu, J.; Williams, T.-A.; Lu, X.; Hsu, S.-I.; et al. Practicality of Intermittent Fasting in Humans and Its Effect on Oxidative Stress and Genes Related to Aging and Metabolism. Rejuvenation Res. 2015, 18, 162–172. DOI: 10.1089/rej.2014.1624.
  • Sleiman, S.-F.; Henry, J.; Al-Haddad, R.; El Hayek, L.; Abou Haidar, E.; Stringer, T.; Ulja, D.; Karuppagounder, -S.-S.; Holson, E.-B.; Ratan, R.-R.; et al. Exercise Promotes the Expression of Brain Derived Neurotrophic Factor (BDNF) through the Action of the Ketone Body Beta-Hydroxybutyrate. ELife. 2016, 5, e15092. DOI: 10.7554/eLife.15092.
  • Mattson, M.-P.; Longo, V.-D.; Harvie, M. Impact of Intermittent Fasting on Health and Disease Processes. Ageing Res. Rev. 2017, 39, 46–58. DOI: 10.1016/j.arr.2016.10.005.
  • Mattison, J.-A.; Colman, R.-J.; Beasley, T.-M.; Allison, D.-B.; Kemnitz, J.-W.; Roth, G.-S.; Ingram, D.-K.; Weindruch, R.; de Cabo, R.; Anderson, R.-M. Caloric Restriction Improves Health and Survival of Rhesus Monkeys. Nat. Commun. 2017, 8, 14063. DOI: 10.1038/ncomms14063.
  • White, E.; Mehnert, J.-M.; Chan, C.-S. Autophagy, Metabolism, and Cancer. Clin. Cancer Res. 2015, 21(22), 5037–5046. DOI: 10.1158/1078-0432.CCR-15-0490.
  • Zhou, Y.; Zhao, R.-H.; Tseng, K.-F.; Li, K.-P.; Lu, Z.-G.; Liu, Y.; Han, K.; Gan, Z.-H.; Lin, S.-C.; Hu, H.-Y.; et al. Sirolimus Induces Apoptosis and Reverses Multidrug Resistance in Human Osteosarcoma Cells in Vitro via Increasing microRNA-34b Expression. Acta Pharmacol. Sin. 2016, 37(4), 519–529. DOI: 10.1038/aps.2016.30.
  • Tinsley, G.-M.; Bounty, P.-M.-L. Effects of Intermittent Fasting on Body Composition and Clinical Health Markers in Humans. Nutr. Rev. 2015, 73(10), 661–674. DOI: 10.1093/nutrit/nuv041.
  • Imai, S.-I.;. SIRT1 and Caloric Restriction: An Insight into Possible Trade-Offs between Robustness and Frailty. Curr. Opin. Clin. Nutr. Metab. Care. 2009, 12(4), 350. DOI: 10.1097/MCO.0b013e32832c932d.
  • Abd El-Kader, S.-M.; Saiem Al-Dahr, M.-H. Impact of Weight Loss on Oxidative Stress and Inflammatory Cytokines in Obese Type 2 Diabetic Patients. Afr. Health Sci. 2016, 16, 725–733. DOI: 10.4314/ahs.v16i3.12.
  • Baumeier, C.; Kaiser, D.; Heeren, J.; Scheja, L.; John, C.; Weise, C. Caloric Restriction and Intermittent Fasting Alter Hepatic Lipid Droplet Proteome and Diacylglycerol Species and Prevent Diabetes in NZO Mice. Biochim. Biophys. Acta. 2015, 1851, 566e576.
  • Park, S.; Yoo, K.-M.; Hyun, J.-S.; Kang, S. Intermittent Fasting Reduces Body Fat but Exacerbates Hepatic Insulin Resistance in Young Rats Regardless of High Protein and Fat Diets. J. Nutr. Biochem. 2017, 40, 14–22. DOI: 10.1016/j.jnutbio.2016.10.003.
  • Linden, M.-A.; Lopez, K.-T.; Fletcher, J.-A.; Morris, E.-M.; Meers, G.-M.; Siddique, S.; Laughlin, M.-H.; Sowers, J.-R.; Thyfault, J.-P.; Ibdah, J.-A. Combining Metformin Therapy with Caloric Restriction for the Management of Type 2 Diabetes and Nonalcoholic Fatty Liver Disease in Obese Rats. Appl. Physiol. Nutr. Metab. 2015, 40(10), 1038–1047. DOI: 10.1139/apnm-2015-0236.
  • Chung, H.; Chou, W.; Sears, -D.-D.; Patterson, R.-E.; Webster, N.-J.; Ellies, L.-G. Time-Restricted Feeding Improves Insulin Resistance and Hepatic Steatosis in a Mouse Model of Postmenopausal Obesity. Metabolism. 2016, 65, 1743e 1754. DOI: 10.1016/j.metabol.2016.09.006.
  • Hodakoski, C.; Hopkins, B.-D.; Barrows, D.; Mense, S.-M.; Keniry, M.; Anderson, K.-E.; Kern, P.-A.; Hawkins, P.-T.; Stephens, L.-R.; Parsons, R. Regulation of PTEN Inhibition by the Pleckstrin Homology Domain of P-REX2 during Insulin Signaling and Glucose Homeostasis. Proc. Natl. Acad. Sci. U. S. A. 2014, 111, 155–160. DOI: 10.1073/pnas.1213773111.
  • Montagner, A.; Polizzi, A.; Fouche, E.; Ducheix, S.; Lippi, Y.; Lasserre, F.; Barquissau, V.; Régnier, M.; Lukowicz, C.; Benhamed, F.; et al. Liver PPARalpha Is Crucial for Whole-Body Fatty Acid Homeostasis and Is Protective against NAFLD. Gut. 2016, 65, 1202e1214. DOI: 10.1136/gutjnl-2015-310798.
  • Contreras, A.-V.; Torres, N.; Tovar, A.-R. PPAR-alpha as a Key Nutritional and Environmental Sensor for Metabolic Adaptation. Adv. Nutr. 2013, 4, 439e452. DOI: 10.3945/an.113.003798.
  • Yan, F.; Wang, Q.; Xu, C.; Cao, M.; Zhou, X.; Wang, T.; Yu, C.; Jing, F.; Chen, W.; Gao, L.; et al. Peroxi- Some Proliferator-Activated Receptor Alpha Activation Induces Hepatic Steatosis, Suggesting an Adverse Effect. PLoS One. 2014, 9, e99245. DOI: 10.1371/journal.pone.0099245.
  • Ding, J.; Li, M.; Wan, X.; Jin, X.; Chen, S.; Yu, C.; Li, Y. Effect of miR-34a in Regulating Steatosis by Targeting PPARalpha Expression in Nonalcoholic Fatty Liver Disease. Scientific Rep. 2015, 5, 13729. DOI: 10.1038/srep13729.
  • Carulli, L.; Anzivino, C.; Baldelli, E.; Zenobii, M.-F.; Rocchi, M.-B.; Bertolotti, M. Telomere Length Elongation after Weight Loss Intervention in Obese Adults. Mol. Genet. Metab. 2016, 118, 138–142. DOI: 10.1016/j.ymgme.2016.04.003.
  • Blackburn, G.;. Effect of Degree of Weight Loss on Health Benefits. Obesity Res. 1995, 3, 211S–216S. DOI: 10.1002/j.1550-8528.1995.tb00466.x.
  • Martinez de la Escalera, L.; Kyrou, I.; Vrbikova, J.; Hainer, V.; Sramkova, P.; Fried, M.; Piya, M.-K.; Kumar, S.; Tripathi, G.; McTernan, P.-G. Impact of Gut Hormone FGF-19 on Type-2 Diabetes and Mitochondrial Recovery in a Prospective Study of Obese Diabetic Women Undergoing Bariatric Surgery. BMC Med. 2017, 15, 34. DOI: 10.1186/s12916-017-0797-5.
  • Thazhath, -S.-S.; Wu, T.; Bound, M.-J.; Checklin, H.-L.; Standfield, S.; Jones, K.-L.; Horowitz, M.; Rayner, C.-K. Effects of Intraduodenal Hydroxycitrate on Glucose Absorption, Incretin Release, and Glycemia in Response to Intraduodenal Glucose Infusion in Health and Type 2 Diabetes: A Randomised Controlled Trial. Nutrition. 2016, 32(5), 553–559. DOI: 10.1016/j.nut.2015.11.004.
  • Ratziu, V.; Harrison, S.-A.; Francque, S.; Bedossa, P.; Lehert, P.; Serfaty, L.; Romero-Gomez, M.; Boursier, J.; Abdelmalek, M.; Caldwell, S.; et al. Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-Alpha and -Delta, Induces Resolution of Nonalcoholic Steatohepatitis without fibrosis Worsening. Gastroenterology. 2016, 150, 1147e1159 e1145. DOI: 10.1053/j.gastro.2016.01.038.
  • Pawlak, M.; Lefebvre, P.; Staels, B. Molecular Mechanism of PPAR- Alpha Action and Its Impact on Lipid Metabolism, Inflammation and fibrosis in Non-Alcoholic Fatty Liver Disease. J. Hepatol. 2015, 62, 720e733. DOI: 10.1016/j.jhep.2014.09.033.